Cefepime Market

Cefepime is a fourth-generation cephalosporin.Its antibacterial spectrum has been further expanded, and it has strong antibacterial activity against a variety of gram-positive and negative bacteria, including enterobacteria, pseudomonas aeruginosa and other non-fermenter bacilli, haemophilus, staphylococcus, etc.Used for various infections caused by sensitive bacteria, mainly for respiratory tract infections caused by vicarious infections such as s. aureus, e. coli and pseudomonas aeruginosa.

Cefepime Market contains market size and forecasts of Cefepime in global, including the following market information:

Global Cefepime Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global Cefepime Market Sales, 2017-2022, 2023-2028, (K Units)

Global top five Cefepime companies in 2021 (%)

The global Cefepime market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Intramuscular Injection Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Cefepime include Baxter, Apotex, B. Braun Medical, Pfizer, Perrigo, Fresenius Kabi, Sandoz (Novartis), Piramal Critical Care and Meitheal Pharmaceuticals, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

We surveyed the Cefepime manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Cefepime Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Cefepime Market Segment Percentages, by Type, 2021 (%)

Intramuscular Injection

Intravenous Drug Delivery

Global Cefepime Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Cefepime Market Segment Percentages, by Application, 2021 (%)

Lower Respiratory Tract Infection

Urinary Tract Infection

Skin And Soft Tissue Infections

Abdominal Cavity Infection

Gynecologic Infection

Sepsis

Neutrophilic Fever

Global Cefepime Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Cefepime Market Segment Percentages, By Region and Country, 2021 (%)

North America

US

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Nordic Countries

Benelux

Rest of Europe

Asia

China

Japan

South Korea

Southeast Asia

India

Rest of Asia

South America

Brazil

Argentina

Rest of South America

Middle East & Africa

Turkey

Israel

Saudi Arabia

UAE

Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Cefepime revenues in global market, 2017-2022 (Estimated), ($ millions)

Key companies Cefepime revenues share in global market, 2021 (%)

Key companies Cefepime sales in global market, 2017-2022 (Estimated), (K Units)

Key companies Cefepime sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

Baxter

Apotex

B. Braun Medical

Pfizer

Perrigo

Fresenius Kabi

Sandoz (Novartis)

Piramal Critical Care

Meitheal Pharmaceuticals

BMS

Qilu Pharmaceutical

Sinopharm

Shanghai Xinfeng Pharmaceutical

Hebei Huamin Pharmaceutical

Nanjing Haichen Pharmaceutical

Shandong Luoxin Pharmaceutical Group

Guangzhou Baiyunshan Tianxin Pharmaceutical

Yuekang Pharmaceutical Group

Chengdu Beite Pharmaceutical

Jiangsu Hengrui Pharmaceutical

Hainan Star Pharmaceutical

Hainan Hailing Pharmaceutical

Shenzhen Xinlitai Pharmaceutical

Shenzhen Lijian Pharmaceutical

Suzhou Dongrui Pharmaceutical